US 7,517,967 B2
Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
Malaya Chatterjee, Fort Wright, Ky. (US); Kenneth A. Foon, Fremont, Calif. (US); and Sunil K. Chatterjee, Fort Wright, Ky. (US)
Assigned to University of Kentucky Research Foundation, Lexington, Ky. (US)
Filed on Mar. 23, 2005, as Appl. No. 11/89,266.
Application 11/089266 is a continuation of application No. 10/153401, filed on May 21, 2002, abandoned.
Application 10/153401 is a continuation of application No. 09/293533, filed on Apr. 15, 1999, granted, now 6,509,016.
Application 09/293533 is a continuation of application No. 08/752844, filed on Nov. 21, 1996, granted, now 5,935,821.
Application 08/752844 is a continuation in part of application No. 08/591196, filed on Jan. 16, 1996, granted, now 5,977,316.
Application 08/591196 is a continuation in part of application No. 08/372676, filed on Jan. 17, 1995, granted, now 5,612,030.
Prior Publication US 2005/0287148 A1, Dec. 29, 2005
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 16/00 (2006.01); A61K 39/395 (2006.01)
U.S. Cl. 530—388.8  [530/387.1; 530/387.7; 530/388.1; 424/130.1; 424/138.1; 424/141.1; 424/155.1] 5 Claims
 
1. A monoclonal antibody 1A7 produced from hybridoma cell line deposited under ATCC Accession No. HB-11786.